Stock Updates

A look at a High Market Cap Stock: St. Jude Medical Inc., STJ

St. Jude Medical Inc., STJ is in the exchange NYSE and its industry is Medical Appliances & Equipment in the sector of Healthcare. Based in USA, St. Jude Medical Inc., STJĀ  has a market cap of 22836.37. Since its IPO date on the 12/7/1989, St. Jude Medical Inc., STJ performance year to date is 31.74%. Today St. Jude Medical Inc., STJ has gained 0.54%, with a current price of 80.58.

Ownership of the company is 0.10% for insider ownership while institutional ownership is 85.70%. The management of the company have seen the company have a payout ratio of 46.70%. Return of assets are at 6.10%, with return on investment at 9.30%.

In terms of debt levels and profit levels, St. Jude Medical Inc., STJ is seeing a long-term debt/equity of 1.36. While Total debt/equity is 1.48. With a profit margin of 12.60%, this is combined with a gross margin of 67.50%, and operating margin of 16.50%. St. Jude Medical Inc. ability to meet debt levels, with a current ratio of 1.7, while the quick ratio is 1.1.

For the last year St. Jude Medical Inc., STJ has seen a EPS growth of -11.10%. A performance for the year of 10.18%. The 52-week high is 0.51%, and the 52-week low is 66.65%. The average volume for St. Jude Medical Inc., STJ is 1186619.

With a target price of 72.67, can St. Jude Medical Inc., STJ reach this target? Looking at the value indicators of St. Jude Medical Inc., STJ. St. Jude Medical Inc. has a P/E of 32.32 and a forward P/E of 18.26. Perhaps the more useful indicator than P/E, is PEG which has a value of 3.14. St. Jude Medical Inc. also has a P/S and a P/B of 4.05 and 5.57 respectively. For P/cash, St. Jude Medical Inc. has a value of 70.27, while it is 55.16 for P/free cash flow.

At the current price of 80.58, St. Jude Medical Inc. has a dividend yield of 1.54%. We see a return on equity of 17.80%.

Looking more long-term St. Jude Medical Inc., is projected to get an EPS growth for the next five years of 10.29%. In the short-term an EPS growth of 8.67% in the next year is forecasted. This is after a EPS growth of -11.10% for this year and for the last five years a 2.30% growth has been seen.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment